Sue Decotiis
Dr. Sue Decotiis is a triple board-certified weight loss specialist based in New York City, recognized for her expertise in obesity management and metabolic health. In recent discussions, she commented on the findings of a study involving liraglutide, emphasizing its limited use in weight loss despite its potential benefits for migraine sufferers.
Not in the pool (under ¢1).
Recent news mentions
Dr. Sue Decotiis, a New York City weight loss physician, discusses how GLP-1s impact inflammation, relieving conditions from arthritis to cancer.
Weight-loss drugs could increase risk of malnutrition-related disease
United States· 2026-02-13
Dr. Sue Decotiis, a New York City weight loss physician, discusses how GLP-1s impact inflammation, relieving conditions from arthritis to cancer.
FDA has approved first oral GLP-1 weight-loss drug in the USUnited States· 2025-12-24
Dr. Sue Decotiis, a New York City weight loss physician, discusses how GLP-1s impact inflammation, relieving conditions from arthritis to cancer.
Everyday medications could impact gut health long term, study findsUnited States· 2025-10-17
Sue Decotiis, M.D., a medical weight-loss doctor in New York City, noted in a separate interview with Fox News Digital that the use of obesity and diabetes drugs has been associated with reducing cancer risk.
Obesity-related cancer deaths have more than tripled in US over past two decadesUnited States· 2025-08-05
Sue Decotiis, M.D., a medical weight-loss doctor in New York City, said that in her own practice, she’s witnessed patients experience 'tremendous relief' for inflammatory arthritis disease after taking GLP-1s.
Diabetes and weight-loss drugs may also relieve arthritis symptomsUnited States· 2025-08-02
Dr. Sue Decotiis, a triple board-certified weight loss specialist in New York City, commented on liraglutide's effectiveness.
Weight-loss drug reduced migraine frequency in small studyUnited States· 2025-07-05
